Changfeng Pharmaceuticals: Signs Strategic Cooperation Agreement with JD Health

MetaMuskRat · 2026-03-23T07:20:38+00:00

Longfeng Pharmaceuticals and JD Health have signed a three-year strategic cooperation agreement. JD Health will serve as the online launch platform for the company's new respiratory and otolaryngology products, providing sales and patient service support, enhancing product commercialization efficiency, and exploring cooperative models for internet-based chronic disease management in medical care.

MetaMuskRat

2026-03-23 07:20:38

Abstract generation in progress

People’s Financial News, March 23 — Changfeng Pharmaceutical announced on the Hong Kong Stock Exchange that on March 20, 2026, the company officially signed a strategic cooperation agreement with JD Health. According to the agreement, JD Health will serve as the exclusive online launch platform for several of the company’s upcoming major new products in the respiratory and ENT fields over the next three years. The main points of cooperation include: (i) JD Health will leverage its online platform and supply chain capabilities to support online product launches and patient services; (ii) JD Health will use its expertise in prescription handling and patient management to help improve the commercialization efficiency of the new products; and (iii) both parties will explore internet-based chronic disease management cooperation models.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.